Evidence map›Paper›PMID 30885556›Full record

ArticleJournal of pediatric surgery2019

Association between image-defined risk factors and neuroblastoma outcomes.

Hannah M Phelps, Josephine M Ndolo, Kyle J Van Arendonk, Heidi Chen, Hannah L Dietrich, Katherine D Watson, Melissa A Hilmes, Dai H Chung, Harold N Lovvorn

Abstract read
In one paragraph

Article in Journal of pediatric surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. High-Risk Neuroblastoma: A Surgical Perspective.Children (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Effects of preoperative chemotherapy on neuroblastoma withWorld journal of pediatric surgery · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hannah M PhelpsSchool of Medicine, Vanderbilt University Medical Center, Nashville, TN; Surgical Outcomes Center for Kids, Vanderbilt University Medical Center, Nashville, TN. Electronic address: hannah.m.phelps@vanderbilt.edu.
Josephine M NdoloDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN.
Kyle J Van ArendonkDepartment of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN.
Heidi ChenSurgical Outcomes Center for Kids, Vanderbilt University Medical Center, Nashville, TN; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
Hannah L DietrichSchool of Nursing, Vanderbilt University Medical Center, Nashville, TN.
Katherine D WatsonDepartment of Pediatrics, Division of Pediatric Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN.
Melissa A HilmesDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN.
Dai H ChungDepartment of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN.
Harold N LovvornSurgical Outcomes Center for Kids, Vanderbilt University Medical Center, Nashville, TN; Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN.

Funding

Persistent SIX2 expression as a first hit mechanism in Wilms tumorigenesisR03CA182063 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LOVVORN, HAROLD NEWTON · 2015 to 2016
$157k
NCI NIH HHS R03 CA182063
6 · The paper itself

Abstract

backgroundThe current neuroblastoma (NBL) staging system employs image-defined risk factors (IDRFs) to assess numerous anatomic features, but the impact of IDRFs on surgical and oncologic outcomes is unclear.

methodsThe Vanderbilt Cancer Registry identified children treated for NBL from 2002 to 2017. Tumor volume (TV) and IDRFs were measured radiographically at diagnosis and before resection. Perioperative and oncologic outcomes were evaluated.

resultsAt diagnosis of 106 NBL, 61% were IDRF positive. MYCN-amplified and undifferentiated NBL had more IDRFs than nonamplified and more differentiated tumors (p = 0.001 and p = 0.01). Of 86 NBLs resected, 43% were IDRF positive, which associated with higher stage, risk, and TV (each p < 0.001). The presence of IDRF at resection was also associated with increased blood loss (p < 0.001), longer operating times (p < 0.001), greater incidence of intraoperative complications (p = 0.03), more frequent ICU admissions postoperatively (p < 0.001), and longer hospital stays (p < 0.001). IDRF negative and positive tumors did not have significantly different rates of gross total resection (p = 0.2). Five-year relapse-free and overall survival was similar for IDRF negative and positive NBL (p = 0.9 and p = 0.8).

conclusionsIDRFs at diagnosis were associated with larger, less differentiated, advanced stage, and higher risk NBL and at resection with increased operative difficulty and perioperative morbidity. However, the frequency of gross total resection and patient survival after resection were not associated with the presence of IDRFs. TYPE OF STUDY: Retrospective cohort study. LEVEL OF EVIDENCE: Level III.

Indexed as

Neoplasm StagingNeuroblastomaDisease-Free SurvivalHumansRetrospective StudiesRisk FactorsImage-defined risk factorsInternational neuroblastoma risk groupNeuroblastomaTumor volume

Identifiers

PMID30885556
PMCPMC6628713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.